Delhi AIIMS chief Dr. Randeep Guleria said that Covaxin's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month.
from Zee News :India National https://ift.tt/3xFV2wH
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.
0 Comments